{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:06:24Z","timestamp":1790762784999,"version":"4.1.0"},"reference-count":40,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1507\/endocrj.k07e-065","type":"journal-article","created":{"date-parts":[[2008,5,12]],"date-time":"2008-05-12T05:50:25Z","timestamp":1210571425000},"page":"381-389","source":"Crossref","is-referenced-by-count":30,"title":["Hypothyroidism Results in Small Dense LDL Independent of IRS Traits and Hypertriglyceridemia"],"prefix":"10.1507","volume":"55","author":[{"given":"Jasem M. K.","family":"ABBAS","sequence":"first","affiliation":[{"name":"Division of Clinical Biochemistry, Mubarak Al-Kabeer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"CHAKRABORTY","sequence":"additional","affiliation":[{"name":"Departments of Medical Laboratory Sciences, Kuwait University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abayomi O.","family":"AKANJI","sequence":"additional","affiliation":[{"name":"Departments of Pathology, Kuwait University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail A. R.","family":"DOI","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Mubarak Al-Kabeer Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rizzo M, Berneis K (2006) Low-density lipoprotein size and cardiovascular risk assessment. QJM 99: 1-14.","DOI":"10.1093\/qjmed\/hci154"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sacks FM, Campos H (2003) Clinical review 163: Cardiovascular endocrinology: Low-density lipoprotein size and cardiovascular disease: a reappraisal. J Clin Endocrinol Metab 88: 4525-4532.","DOI":"10.1210\/jc.2003-030636"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R200004-JLR200"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, <i>et al<\/i>. (2006) Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J 47: 405-414.","DOI":"10.3349\/ymj.2006.47.3.405"},{"key":"6","unstructured":"6. Rizzo M, Berneis K, Corrado E, Novo S (2006) The significance of low-density-lipoproteins size in vascular diseases. Int Angiol 25: 4-9."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1159\/000012806"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02326.x"},{"issue":"2","key":"9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5551\/jat.12.67","volume":"12","author":"HIRANO TSUTOMU","year":"2005","ISSN":"https:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al. (2001) Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 47: 266-274.","DOI":"10.1093\/clinchem\/47.2.266"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hirany SV, Othman Y, Kutscher P, Rainwater DL, Jialal I, Devaraj S (2003) Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis. Am J Clin Pathol 119: 439-445.","DOI":"10.1309\/H4E6KTYUFFF23HFN"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ensign W, Hill N, Heward CB (2006) Disparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristics. Clin Chem 52: 1722-1727.","DOI":"10.1373\/clinchem.2005.059949"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gazi I, Lourida ES, Filippatos T, Tsimihodimos V, Elisaf M, Tselepis AD (2005) Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human Plasma. Clin Chem 51: 2264-2273.","DOI":"10.1373\/clinchem.2005.058404"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(98)00201-9"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132: 270-278.","DOI":"10.7326\/0003-4819-132-4-200002150-00004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, <i>et al<\/i>. (2005) Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165: 2467-2472.","DOI":"10.1001\/archinte.165.21.2467"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031089"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90531-H"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344: 501-509.","DOI":"10.1056\/NEJM200102153440707"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M (2000) Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magnetic resonance imaging. J Clin Endocrinol Metab 85: 1822-1827.","DOI":"10.1210\/jcem.85.5.6520"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, <i>et al<\/i>. (1997) Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7: 411-414.","DOI":"10.1089\/thy.1997.7.411"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hamano K, Inoue M (2005) Increased risk for atherosclerosis estimated by pulse wave velocity in hypothyroidism and its reversal with appropriate thyroxine treatment. Endocr J 52: 95-101.","DOI":"10.1507\/endocrj.52.95"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2004.05.068"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, <i>et al<\/i>. (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95: 69-75.","DOI":"10.1161\/01.CIR.95.1.69"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. St-Pierre AC, Cantin B, Dagenais GR, Mauriege P, Bernard PM, Despres JP, <i>et al<\/i>. (2005) Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Quebec Cardiovascular Study. Arterioscler Thromb Vasc Biol 25: 553-559.","DOI":"10.1161\/01.ATV.0000154144.73236.f4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Austin MA, Jarvik GP, Hokanson JE, Edwards K (1993) Complex segregation analysis of LDL peak particle diameter. Genet Epidemiol 10: 599-604.","DOI":"10.1002\/gepi.1370100645"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Tribble DL, Rizzo M, Chait A, Lewis DM, Blanche PJ, Krauss RM (2001) Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. Am J Med 110: 103-110.","DOI":"10.1016\/S0002-9343(00)00700-2"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.260.13.1917"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP Jr, Mayer EJ, <i>et al<\/i>. (1993) LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381-387.","DOI":"10.1161\/01.CIR.88.2.381"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Austin MA, King MC, Vranizan KM, Krauss RM (1990) Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82: 495-506.","DOI":"10.1161\/01.CIR.82.2.495"},{"key":"31","unstructured":"31. Sniderman AD, Rosenbloom M (2005) If apoB is so good, why isn't everybody measuring it? One reason why we need The Netherlands Journal of Medicine! Neth J Med 63: 232-235."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Guerin M, Le Goff W, Lassel TS, Van Tol A, Steiner G, Chapman MJ (2001) Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia. Arterioscler Thromb Vasc Biol 21: 282-288.","DOI":"10.1161\/01.ATV.21.2.282"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R200008-JLR200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ikewaki K, Noma K, Tohyama J, Kido T, Mochizuki S (2005) Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study. Int J Cardiol 101: 441-447.","DOI":"10.1016\/j.ijcard.2004.03.071"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Superko HR, Berneis KK, Williams PT, Rizzo M, Wood PD (2005) Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A. Am J Cardiol 96: 1266-1272.","DOI":"10.1016\/j.amjcard.2005.06.069"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Elisaf M (2002) Effects of fibrates on serum metabolic parameters. Curr Med Res Opin 18: 269-276.","DOI":"10.1185\/030079902125000516"},{"key":"37","unstructured":"37. Jonkers IJ, Smelt AH, van der Laarse A (2001). Hypertriglyceridemia: associated risks and effect of drug treatment. Am J Cardiovasc Drugs 1: 455-466."},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12663-3"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000130484.20501.df"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021993"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/2\/55_K07E-065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:47:23Z","timestamp":1618296443000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/55\/2\/55_K07E-065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k07e-065","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}